T3	total-participants 556 558	41
T4	eligibility 86 129	breast cancer survivors on hormonal therapy
T5	control 835 873	daily multivitamin (control condition)
T9	outcome 1176 1189	Hypercalcemia
T10	outcome 1398 1421	improved bone formation
T11	outcome 1568 1602	improve any of the bone biomarkers
T1	intervention 15 63	high-dose calcitriol and individualized exercise
T2	outcome-Measure 914 953	changes in biomarkers of bone formation
T6	outcome-Measure 955 970	bone resorption
T7	outcome-Measure 980 1001	bone remodeling index
T8	outcome 1499 1520	bone remodeling index
T12	outcome 1663 1677	well tolerated
T13	outcome 1713 1727	bone formation
